Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury
Raphaël Kormann, Audrey Jacquot, Asma Alla, Alice Corbel, Matthieu Koszutski, Paul Voirin, Matthieu Garcia Parrilla, Sybille Bevilacqua, Evelyne Schvoerer, Jean-Louis Gueant, Farès Namour, Bruno Levy, Luc Frimat, Abderrahim Oussalah, Raphaël Kormann, Audrey Jacquot, Asma Alla, Alice Corbel, Matthieu Koszutski, Paul Voirin, Matthieu Garcia Parrilla, Sybille Bevilacqua, Evelyne Schvoerer, Jean-Louis Gueant, Farès Namour, Bruno Levy, Luc Frimat, Abderrahim Oussalah
Abstract
Background: Recent data have shown that severe acute respiratory syndrome coronavirus 2 can infect renal proximal tubular cells via Angiotensin Converting Enzyme 2 (ACE2) . Our objective was to determine whether Fanconi syndrome is a frequent clinical feature in coronavirus disease 2019 (COVID-19) patients.
Methods: A retrospective cohort of 42 laboratory-confirmed COVID-19 patients without history of kidney disease hospitalized in University Hospital of Nancy was investigated. Patients were admitted to the intensive care unit (ICU) (n = 28) or the Medical department (n = 14) and were screened at least once for four markers of proximal tubulopathy.
Results: The mean (standard deviation) follow-up was 19.7 (±12.2) days. Of the patients, 75% (30/40) showed at least two proximal tubule abnormalities (incomplete Fanconi syndrome). The main disorders were proteinuria (88%, n = 35), renal phosphate leak defined by renal phosphate threshold/glomerular filtration rate (TmPi/GFR) <0.77 (55%, n = 22), hyperuricosuria (43%, n = 17) and normoglycaemic glycosuria (30%, n = 12). At the time of the first renal evaluation, ICU patients presented more frequent (96 versus 62%, P = 0.0095) and more severe (844 ± 343 versus 350 ± 221 mg/g, P = 0.0001) proteinuria, and a trend for an increased number of proximal tubule abnormalities (P = 0.038). During follow-up, they presented a lower nadir of serum phosphate [median (interquartile range) 0.68 (0.43-0.76) versus 0.77 (0.66-1.07) mmol/L, P = 0.044] and Acute kidney Injury (AKI) during the hospitalization (P = 0.045). Fanconi syndrome preceded severe AKI KDIGO Stages 2 and 3 in 88% (7/8) of patients. Proximal tubular abnormalities (such as proteinuria, TmPi/GFR and glycosuria in five, two and two patients, respectively) were not detected anymore in recovering patients before hospital discharge.
Conclusion: Incomplete Fanconi syndrome is highly frequent in COVID-19 patients and precedes AKI or disappears during the recovery phase.
Keywords: COVID-19; Fanconi syndrome; SARS-CoV-2; acute kidney injury; acute proximal tubule injury; hypophosphataemia.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
Figures
References
- Wu Z, McGoogan JM.. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020; 323: 1239
- Zhang B, Zhou X, Qiu Y. et al. Clinical characteristics of 82 death cases with COVID-19. medRxiv 2020; doi: 2020.02.26.20028191
- Naicker S, Yang C-W, Hwang S-J. et al. The novel coronavirus 2019 epidemic and kidneys. Kidney Int 2020; 97: 824–828
- Bruggeman LA. Common mechanisms of viral injury to the kidney. Adv Chronic Kidney Dis 2019; 26: 164–170
- Prasad N, Novak JE, Patel MR.. Kidney diseases associated with parvovirus B19, Hanta, Ebola, and Dengue virus infection: a brief review. Adv Chronic Kidney Dis 2019; 26: 207–219
- Yeung M-L, Yao Y, Jia L. et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol 2016; 1: 16004.
- Hua S, Ming Y, Cheng W. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020
- Monteil V, Kwon H, Prado P. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 2020; 181: P905–P913.e7
- Vignon M, Javaugue V, Alexander MP. et al. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. Leukemia 2017; 31: 123–129
- Bijvoet OL, Majoor CL.. The renal tubular reabsorption of phosphate in thyrotoxicosis. Clin Chim Acta 1965; 11: 181–183
- Payne RB. Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem 1998; 35: 201–206
- Bollée G, Dahan K, Flamant M. et al. Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin J Am Soc Nephrol 2011; 6: 2429–2438
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter Suppl2012; 2: 1–138
- Le Gall JR, Lemeshow S, Saulnier F.. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963
- Vincent JL, de Mendonça A, Cantraine F. et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793–1800
- Ranieri VM, Rubenfeld GD, Thompson BT. et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526–2533
- Papazian L, Aubron C, Brochard L. et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019; 9: 69.
- Claure-Del Granado R, Mehta RL.. Fluid overload in the ICU: evaluation and management. BMC Nephrol 2016; 17: 109.
- Oussalah A, Ferrand J, Filhine-Tresarrieu P. et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article). Medicine (Baltimore) 2015; 94: e1774.
- Jean R. [Biological syndrome simulating De Toni-Debré-Fanconi syndrome during lead poisoning]. Pediatrie 1956; 11: 263–265
- Gonick H, Indraprasit S, Neustein H. et al. Cadmium-induced experimental Fanconi syndrome. Curr Probl Clin Biochem 1975; 4: 111–118
- Tanaka A, Nishida R, Maeda K. et al. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy? Clin Nephrol 2000; 53: 301–306
- Medland NA, Chow EP, Walker RG. et al. Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate. Int J STD AIDS 2018; 29: 227–236
- Bahr NC, Yarlagadda SG.. Fanconi syndrome and tenofovir alafenamide: a case report. Ann Intern Med 2019; 170: 814–815
- El Hamel C, Thierry A, Trouillas P. et al. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant 2010; 25: 2982–2990
- Stokes MB, Valeri AM, Herlitz L. et al. Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol 2016; 27: 1555–1565
- Kupin WL. Viral-associated GN: hepatitis B and other viral infections. Clin J Am Soc Nephrol 2017; 12: 1529–1533
- Hassan I, Jhaveri KD, Perazella MA.. COVID-19 therapeutic options for patients with kidney disease. Kidney Int 2020. (2 April 2020, date last accessed)
- Tietäväinen J, Mantula P, Outinen T. et al. Glucosuria predicts the severity of Puumala hantavirus infection. Kidney Int Rep 2019; 4: 1296–1303
Source: PubMed